<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05037175</url>
  </required_header>
  <id_info>
    <org_study_id>62509</org_study_id>
    <nct_id>NCT05037175</nct_id>
  </id_info>
  <brief_title>Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for CPT-Text for PTSD</brief_title>
  <acronym>CPT-TEXT</acronym>
  <official_title>Telehealth 2.0: Evaluating Effectiveness and Engagement Strategies for Asynchronous Texting Based Trauma Focused Therapy for PTSD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>The University of Texas Health Science Center at San Antonio</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Talkspace</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Stanford University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a pressing need to increase capacity to treat PTSD related to or exacerbated by the&#xD;
      COVID-19 pandemic. Texting-based therapy holds promise to increase capacity and reduce&#xD;
      barriers to delivering evidence-based treatments (EBTs), but ongoing engagement in digital&#xD;
      mental health interventions is low. This study will compare a texting-based EBT for PTSD to&#xD;
      texting-based treatment as usual, and it will also compare a unique incentive strategy to&#xD;
      typical platform reminders aimed to prevent early discontinuation in therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The COVID-19 pandemic has exacerbated mental health challenges for trauma-exposed individuals&#xD;
      due to increased isolation, insufficient capacity in the mental health workforce, and a&#xD;
      predicted fourth wave of mental health impacts of the pandemic itself. There is a pressing&#xD;
      need to increase treatment capacity. Digital mental health (DMH) interventions for&#xD;
      posttraumatic stress disorder (PTSD) address well-documented barriers to traditional&#xD;
      in-person psychotherapy or telehealth delivery of evidence-based treatments (EBTs) for PTSD,&#xD;
      but many consumers do not remain engaged. Thus, acceptable, efficient, and engaging forms of&#xD;
      EBTs are sorely needed, particularly for those who are less likely to access traditional&#xD;
      psychotherapy or use online programs. Asynchronous texting therapy platforms may facilitate&#xD;
      treatment engagement among those who seek discrete, convenient, and affordable support. In&#xD;
      our pilot of a texting-based format of an EBT for PTSD, Cognitive Processing Therapy&#xD;
      (CPT-Text), we found CPT-Text was feasible to deliver, and clients showed substantially&#xD;
      greater PTSD symptom improvement over a shorter time compared to text therapy as usual (TAU).&#xD;
      A larger scale, more rigorous test is necessary. We propose a randomized, Hybrid Type 1,&#xD;
      effectiveness-implementation trial with a factorial design to compare text-based therapies&#xD;
      for PTSD utilizing the HIPAA-compliant secure texting platform of our DMH partner, Talkspace.&#xD;
      We will randomize participants (N= 400) who have PTSD that is related to or has been&#xD;
      exacerbated by the COVID-19 pandemic into CPT-Text or text-based TAU. Participants will also&#xD;
      be randomized into one of two engagement strategies: therapist reminder as usual (RAU) or RAU&#xD;
      + incentive (RI). We will examine an innovative incentive structure in which participants who&#xD;
      remain engaged in the intervention will have the option of retaining their introductory&#xD;
      discount or donating it to individuals in need of financial support. We will compare the&#xD;
      impact of engagement strategy on treatment response and engagement, and we will examine&#xD;
      motivation as a potential mechanism. We also will evaluate a novel Natural Language&#xD;
      Processing (NLP) approach to assessing CPT-Text fidelity. This study will (1) provide&#xD;
      critical information about how to promote sustained DMH engagement using unique incentive&#xD;
      strategies and moderators of engagement and outcomes and (2) offer first guidance on&#xD;
      supporting quality and fidelity of messaging-based EBTs using NLP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 30, 2021</start_date>
  <completion_date type="Anticipated">September 29, 2024</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PTSD Checklist for DSM-5 (PCL-5)</measure>
    <time_frame>Baseline through 24 weeks</time_frame>
    <description>The PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that evaluates the degree to which individuals have been bothered by PTSD symptoms tied to their most currently distressing event [114] . The monthly version will be administered at baseline and the weekly version thereafter.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Health Questionnaire (PHQ-9)</measure>
    <time_frame>Baseline through 24 weeks</time_frame>
    <description>The PHQ-9 [115,116] is a self-administered version of the PRIME-MD diagnostic instrument for common mental disorders that will be administered on the schedule outlined in the table. The PHQ-9 is the 9-item depression module and is a multipurpose instrument for screening, diagnosing, monitoring, and measuring the severity of depression.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Brief Inventory of Psychosocial Functioning (B-IPF)</measure>
    <time_frame>Baseline through 24 weeks</time_frame>
    <description>The Brief Inventory of Psychosocial Functioning (B-IPF; [117] ) is a 7-item self-report instrument measuring respondents' level of functioning over the past 30 days in seven life domains including: romantic, family, parenting, friendship, work, education, and self-care.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Client Satisfaction Questionnaire (CSQ)</measure>
    <time_frame>Baseline through 24 weeks</time_frame>
    <description>The Client Satisfaction Questionnaire (CSQ; [118] ) is an 8-item measure of participant satisfaction with treatment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Working Alliance Inventory, Short Form (WAI-SF)</measure>
    <time_frame>Week 1 through Week 12</time_frame>
    <description>The Working Alliance Inventory, Short Form (WAI-SF, [125] ) is a measure to index the degree of therapeutic cohesion between the client and the therapist.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Behavioral Intention</measure>
    <time_frame>Baseline through week 8</time_frame>
    <description>Behavioral Intention (BI; which captures motivation to engage in a behavior) will be measured to examine patterns of motivation in our treatment conditions and to investigate BI as the hypothesized mechanism of change in engagement. BI measures are created based on recommendations for constructing a very brief BI measure, a frequent approach to measuring this construct, which has demonstrated reliability [119-123] . Participants will be asked, &quot;How likely or unlikely are you to complete (baseline) or continue (mid-treatment) treatment?&quot; on a 7-item Likert scale ranging from &quot;Extremely Unlikely&quot; to &quot;Extremely Likely&quot; at the baseline and both mid-treatment assessments.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <arm_group>
    <arm_group_label>CPT-Text + Incentive</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPT-Text. CPT is a 12-session, trauma-focused, cognitive therapy that teaches clients to examine and change problematic beliefs about themselves and the world that were altered as a result of trauma.&#xD;
Retention Incentive (RI). Participants will be told at baseline that they can retain their discount in subsequent months if they message with their therapist regularly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CPT-Text + Reminder As Usual</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CPT-Text. CPT is a 12-session, trauma-focused, cognitive therapy that teaches clients to examine and change problematic beliefs about themselves and the world that were altered as a result of trauma.&#xD;
Reminder as Usual (RAU). As per Talkspace guidelines, therapists are available to client participants twice per day, five days per week. In the event a client participant has not engaged or messaged in 48 hours, therapists send a personalized message to the client participant to encourage them to re-engage.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Texting as Usual + Incentive</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TAU. TAU will be conducted by Talkspace therapists with a specialty in PTSD. Retention Incentive (RI). Participants will be told at baseline that they can retain their discount in subsequent months if they message with their therapist regularly.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Texting as Usual + Reminder as Usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>TAU. TAU will be conducted by Talkspace therapists with a specialty in PTSD. Reminder as Usual (RAU). As per Talkspace guidelines, therapists are available to client participants twice per day, five days per week. In the event a client participant has not engaged or messaged in 48 hours, therapists send a personalized message to the client participant to encourage them to re-engage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>CPT-Text</intervention_name>
    <description>CPT is a 12-session, trauma-focused, cognitive therapy that teaches clients to examine and change problematic beliefs about themselves and the world that were altered as a result of trauma. Each session includes psychoeducation and introduction of a new skill or module, which builds on the previous information and skills. Participants will receive psychoeducation video links via Talkspace and an electronic workbook with handouts, written explanations of the concepts and activities, and CPT worksheets, which will be embedded in the platform and sent by the therapist at the appropriate point in the protocol. Therapists encourage the client to complete each module using the provided materials and assist clients in reflecting on their beliefs through Socratic questions and feedback on their worksheets [5,6]. Clients work at their own pace, with therapists sending the skill or module after the client has practiced the previous one.</description>
    <arm_group_label>CPT-Text + Incentive</arm_group_label>
    <arm_group_label>CPT-Text + Reminder As Usual</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Texting as Usual</intervention_name>
    <description>TAU will be conducted by Talkspace therapists with a specialty in PTSD. Based on previous research and Talkspace's analysis of TAU, it is likely TAU will include supportive and client-centered interventions, problem solving, and elements from EBTs such as cognitive-behavioral therapy [5].</description>
    <arm_group_label>Texting as Usual + Incentive</arm_group_label>
    <arm_group_label>Texting as Usual + Reminder as Usual</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Retention Incentive</intervention_name>
    <description>Participants will be told at baseline that they can retain their discount in subsequent months if they message with their therapist regularly. If client participants do not re-engage after 24 hours from the RAU (3 days without engagement), they will receive an automated text-message reminding them to message their therapist regularly (on average, every other business day) in order to get their 30% discount in the next month. They can choose to use the incentive themselves or donate it to Talkspace's assistance fund, which provides free therapy to individuals who demonstrate financial need.</description>
    <arm_group_label>CPT-Text + Incentive</arm_group_label>
    <arm_group_label>Texting as Usual + Incentive</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Reminder as Usual</intervention_name>
    <description>As per Talkspace guidelines, therapists are available to client participants twice per day, five days per week. In the event a client participant has not engaged or messaged in 48 hours, therapists send a personalized message to the client participant to encourage them to re-engage.</description>
    <arm_group_label>CPT-Text + Reminder As Usual</arm_group_label>
    <arm_group_label>Texting as Usual + Reminder as Usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Over the age of 18 residing in the United States; Criterion A event measured by the&#xD;
             Life Events Checklist for DSM-5 (LEC-5); and significant symptoms of PTSD as evidenced&#xD;
             by a score of 33 or above on the PCL-5; PTSD symptoms that began or increased during&#xD;
             the COVID pandemic (per self-report); and ownership of a personal device for texting.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) acute risk for suicidal thoughts and/or behaviors measured by the Columbia Suicide&#xD;
             Severity Rating Scale Lifetime-Recent Screen, and (2) psychosis or substance abuse&#xD;
             that requires prioritization of treatment and/or higher level of care.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shannon Wiltsey-Stirman, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stanford University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shannon L Wiltsey-Stirman, PhD</last_name>
    <phone>650-493-5000</phone>
    <phone_ext>1-2-20007</phone_ext>
    <email>sws1@stanford.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Palo Alto</city>
        <state>California</state>
        <zip>94025</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Shannon Wiltsey Stirman, PhD</last_name>
      <phone>650-493-5000</phone>
      <phone_ext>20007</phone_ext>
      <email>sws1@stanford.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Arango C, Wykes T, Moreno C. Mental health care and COVID-19. Lancet Psychiatry. 2020 Dec;7(12):1013. doi: 10.1016/S2215-0366(20)30480-6.</citation>
    <PMID>33220192</PMID>
  </reference>
  <reference>
    <citation>Czeisler MÃ‰, Lane RI, Petrosky E, Wiley JF, Christensen A, Njai R, Weaver MD, Robbins R, Facer-Childs ER, Barger LK, Czeisler CA, Howard ME, Rajaratnam SMW. Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic - United States, June 24-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14;69(32):1049-1057. doi: 10.15585/mmwr.mm6932a1.</citation>
    <PMID>32790653</PMID>
  </reference>
  <reference>
    <citation>Kaseda ET, Levine AJ. Post-traumatic stress disorder: A differential diagnostic consideration for COVID-19 survivors. Clin Neuropsychol. 2020 Oct - Nov;34(7-8):1498-1514. doi: 10.1080/13854046.2020.1811894. Epub 2020 Aug 26. Review.</citation>
    <PMID>32847484</PMID>
  </reference>
  <reference>
    <citation>Hull TD, Malgaroli M, Connolly PS, Feuerstein S, Simon NM. Two-way messaging therapy for depression and anxiety: longitudinal response trajectories. BMC Psychiatry. 2020 Jun 12;20(1):297. doi: 10.1186/s12888-020-02721-x.</citation>
    <PMID>32532225</PMID>
  </reference>
  <reference>
    <citation>Malgaroli M, Hull TD, Wiltsey Stirman S, Resick P. Message Delivery for the Treatment of Posttraumatic Stress Disorder: Longitudinal Observational Study of Symptom Trajectories. J Med Internet Res. 2020 Apr 29;22(4):e15587. doi: 10.2196/15587.</citation>
    <PMID>32347814</PMID>
  </reference>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 31, 2021</study_first_submitted>
  <study_first_submitted_qc>August 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 8, 2021</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stanford University</investigator_affiliation>
    <investigator_full_name>Shannon Wiltsey Stirman, PhD</investigator_full_name>
    <investigator_title>Associate Professor of Psychiatry and Behavioral Sciences</investigator_title>
  </responsible_party>
  <keyword>Digital Mental Health</keyword>
  <keyword>COVID-19</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Investigators funded under this FOA will share those data via the National Database for Clinical Trials related to Mental Illness in a timely manner. The final quantitative dataset will be de-identified and individual records will include an NIMH Data Archive (NDA) Global Unique identifier when submitted to NDA. The research team will comply with other data submission and sharing requirements and schedule as provided in NIMH Data Archive Data Sharing Terms and Conditions (effective 7/1/15).&#xD;
Due to the sensitive nature of therapy transcripts (even when de-identified), we will request explicit consent for sharing of these data but allow participants to opt out of sharing beyond the research team and institutions.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After publication of main outcome papers for each aim</ipd_time_frame>
    <ipd_access_criteria>Investigators and institutions seeking data from NDA will be expected to meet data security measures, will be asked to submit a Data Use Certification co-signed by the investigator and the designated Institutional Official(s) at the NIH-recognized sponsoring institution with a current Federal Wide Assurance (FWA), and will be require to follow the procedures associated with data access described at https://ndar.nih.gov/ndarpublicweb/policies.go#sop4). Any data directly (e.g., qualitative data, outcome data) shared with other investigators would entail a data use agreement, signed by the research team and institutional authorities, and the individual(s) requesting data.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

